Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8274329 | Journal of the Neurological Sciences | 2016 | 5 Pages |
Abstract
The prevalence of EMO in the survey results was high, significantly lowering the patients' QOL. Interestingly, EMO was also observed in the early stage of the disease. Since the presence of EMO impacts patients' QOL and caregiver burden, medical intervention and appropriate gathering of information for such intervention should be considered.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Rieko Onozawa, Jun Tsugawa, Yoshio Tsuboi, Jiro Fukae, Takayasu Mishima, Shinsuke Fujioka,